Literature DB >> 16815031

Metabolic regulation by the nuclear receptor corepressor RIP140.

Mark Christian1, Roger White, Malcolm G Parker.   

Abstract

Whereas the importance of activating gene expression in metabolic pathways to control energy homeostasis is well established, the contribution of transcriptional inhibition is less well defined. In this review we highlight a crucial role of RIP140, a transcriptional corepressor for nuclear receptors, in the regulation of energy expenditure. Mice devoid of the RIP140 gene are lean, exhibit resistance to high-fat-diet-induced obesity, and have increased glucose tolerance and insulin sensitivity. Consistent with these observations, RIP140 suppresses the expression of gene clusters that are involved in lipid and carbohydrate metabolism, including fatty acid oxidation, oxidative phosphorylation and mitochondrial uncoupling. Therefore, the functional interplay between transcriptional activators and the corepressor RIP140 is an essential process in metabolic regulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815031     DOI: 10.1016/j.tem.2006.06.008

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  48 in total

Review 1.  Transgenic mouse models resistant to diet-induced metabolic disease: is energy balance the key?

Authors:  Laura A A Gilliam; P Darrell Neufer
Journal:  J Pharmacol Exp Ther       Date:  2012-06-13       Impact factor: 4.030

2.  RIP140 directs histone and DNA methylation to silence Ucp1 expression in white adipocytes.

Authors:  Evangelos Kiskinis; Magnus Hallberg; Mark Christian; Martina Olofsson; Stephen M Dilworth; Roger White; Malcolm G Parker
Journal:  EMBO J       Date:  2007-11-01       Impact factor: 11.598

Review 3.  Minireview: the PGC-1 coactivator networks: chromatin-remodeling and mitochondrial energy metabolism.

Authors:  Jiandie D Lin
Journal:  Mol Endocrinol       Date:  2008-11-13

Review 4.  Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations.

Authors:  Aurélia De Pauw; Silvia Tejerina; Martine Raes; Jaap Keijer; Thierry Arnould
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

Review 5.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

6.  Elevated expression of the metabolic regulator receptor-interacting protein 140 results in cardiac hypertrophy and impaired cardiac function.

Authors:  Asmaà Fritah; Jennifer H Steel; Donna Nichol; Nadeene Parker; Sharron Williams; Anthony Price; Leena Strauss; Timothy A Ryder; Margaret A Mobberley; Matti Poutanen; Malcolm Parker; Roger White
Journal:  Cardiovasc Res       Date:  2010-01-18       Impact factor: 10.787

Review 7.  Negative regulators of brown adipose tissue (BAT)-mediated thermogenesis.

Authors:  Bal Krishan Sharma; Mallikarjun Patil; Ande Satyanarayana
Journal:  J Cell Physiol       Date:  2014-12       Impact factor: 6.384

8.  Role of Receptor-Interacting Protein 140 in human fat cells.

Authors:  Niklas Mejhert; Jurga Laurencikiene; Amanda T Pettersson; Maria Kaaman; Britta M Stenson; Mikael Rydén; Ingrid Dahlman
Journal:  BMC Endocr Disord       Date:  2010-01-29       Impact factor: 2.763

9.  A negative regulatory pathway of GLUT4 trafficking in adipocyte: new function of RIP140 in the cytoplasm via AS160.

Authors:  Ping-Chih Ho; Yi-Wei Lin; Yao-Chen Tsui; Pawan Gupta; Li-Na Wei
Journal:  Cell Metab       Date:  2009-12       Impact factor: 27.287

10.  The transcriptional corepressor RIP140 regulates oxidative metabolism in skeletal muscle.

Authors:  Asha Seth; Jennifer H Steel; Donna Nichol; Victoria Pocock; Mande K Kumaran; Asmaa Fritah; Margaret Mobberley; Timothy A Ryder; Anthea Rowlerson; James Scott; Matti Poutanen; Roger White; Malcolm Parker
Journal:  Cell Metab       Date:  2007-09       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.